Role of Neurooncologists in Management of HER2+ Breast Cancer and Brain Metastases

Video

A look at the evolving role of neurooncologists in the treatment of patients with HER2+ breast cancer and brain metastases and future perspectives in the management of this patient population.

Related Videos
Administering immunotherapy following surgery in patients with early-stage triple-negative breast cancer does not appear to be as effective as beginning with neoadjuvant treatment, says Peter Schmid, MD, PhD.
Heather A. Parsons, MD, MPH, says she is excited about HER2 as a biomarker and investigating the biology of metastatic breast cancer with a minimally invasive liquid biopsy platform.
Experts on MM
Experts on NSCLC
Experts on NSCLC
Experts on MM
A panel of 4 experts on multiple myeloma seated at a long table
Experts on MM
Related Content